WhaleTales adds regulatory and political coverage, mainstream crypto news, and market analysis to Aether’s multi-asset financial media portfolio New York, NY, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Alpha Edge Media, Inc., a wholly owned subsidiary of Aether Holdings, Inc. (NASDAQ: ATHR), today announced the acquisition of WhaleTales, an online cryptocurrency-focused newsletter published on the beehiiv platform. Alpha Edge Media is a digital-first financial media company that builds, acquires, and scales newslet ...

Sales launch marks pivotal commercial milestone, unlocking up to $30 million in potential revenue through 2028GAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its collaboration with Sygnature Discovery, a leading contract resear ...

除美国外，SuperX近期在日本、中国等市场都展开了紧锣密鼓的布局动作。 7月28日，SuperX宣布旗下子公司SuperX Industries Pte.Ltd.计划在日本建立其首个区域人工智能供应中 心，该中心预计2025年下半年投产，全面投入运营后，将具备每年为1万台SuperX自有品牌高性能AI服 务器进行最终组装、系统集成与严格品控的交付能力。AI供应中心将专注于公司品牌核心产品(包括高 性能人工智能服务器、高压直流(HVDC)电源系统和高密度液体冷却解决方案)的最终组装、系统集成和 质量控制，能够为日本及亚洲客户提供更快速、更贴近本地需求的交付体验。 7月30日，SuperX正式发布最新旗舰产品SuperX XN9160-B200AI服务器。该服务器搭载NVIDIA最新一 代Blackwell架构GPU(B200)，旨在满足客户对人工智能(AI)、机器学习(ML)和高性能计算(HPC)应用程 序的高性能和可扩展性的算力需求。 9月15日，SuperX子公司牵手中国数字能源企业中恒电气（002364）设立合资公司SuperX Digital Power Pte.Ltd，双方将整合在客户资源、技术储备 ...

Accessibility StatementSkip Navigation The new ONE1600ER module combined with enhancements to the MAP-300 portfolio help customers meet AI- driven demands CHANDLER, Ariz., Sept. 25, 2025 /PRNewswire/ --Â VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) has expanded the functionality of its award-winning ONE LabPro testing and validation platform. Following the launches of the ONE-1600 and second generation ONE-1600IE solutions, the new ONE-1600ER module delivers enhanced features and enables comprehensive testin ...

发行方案 - 公司宣布进行包销公开发行 涉及8,334,000股A类普通股 每股价格3美元 总收益约2,500万美元[1] - 若超额配售权全额行使 将额外发行1,250,100股 总收益增至2,875万美元[4] - 发行预计于2025年9月29日左右完成 需满足多伦多证券交易所等监管机构批准条件[4] 发行条款 - 招股说明书补充文件在加拿大各省（魁北克除外）根据国家文件44-102提交[2] - 在美国通过Rule 144A私募方式向合格机构买家发行 豁免1933年证券法注册要求[2] - 发行由Stifel Nicolaus Canada Inc牵头 联合Canaccord Genuity Corp和Beacon Securities Limited承销[3] 资金用途与文件获取 - 净收益将用于营运资金及一般公司用途[5] - 招股说明书补充文件及基础架構招股书可通过SEDAR+网站或公司联系方式获取[6][7] 公司业务 - 公司为全球3D地理空间产品和智能解决方案领导者 专注于高分辨率地形数据创建与分析[11] - 通过多源数据集整合 为国防、航空、保险、电信等20余个行业提供地理空间智能解决方案[11] - 拥有全球最大的多传感器高程数据专有数据库 支持人工智能与机器学习分析[11]

Key Takeaways The Fed's 25 bps rate cut and projections for more create a favorable backdrop for fintech growth.CSGP, PYPL, SOFI, IBKR and HOOD are highlighted as top investment picks.All five companies show strong revenue and earnings growth expectations for the current year.On Sept. 17, the Fed in its FOMC meeting decided on a much-hyped 25-basis-point cut in the benchmark lending rate to reduce it to the range of 4-4.25%. This is the first interest rate cut of this year. Moreover, the Fed’s dot-plot has ...

Eli Lilly has revealed it is to build an active pharmaceutical product (API) facility in Texas, US, a week after revealing Virginia as the first site in its $27bn US manufacturing drive. The $6.5bn manufacturing facility will produce Eli Lilly’s array of small molecule therapeutics – chief among which will be orforglipron, the drugmaker’s oral glucagon-like peptide-1 receptor agonist (GLP-1RA) hopeful in obesity treatment. Lilly’s CEO David Ricks said: "Our new Houston site will enhance Lilly's ability t ...

Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded dividend stock research firms and running his own dividend investing YouTube channel. He is a Professional Engineer and Project Management Professional and holds a B.S. in Civil Engineering & Mathematics from the United States Military Academy at West Point and has a Masters in Engineering from Texas A&M with a focus on applied mathematics and machine learning.Samuel leads the High Yield Inve ...

SAN MATEO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced its participation in a drug development panel at Fierce Biotech Week taking place October 7-9, 2025 in Boston, MA. Panel Title:How Biotechs are Leveraging Artificial Intelligence (AI)/Machine Learning (ML) to Drive Efficiency and ROIPresenter: Marie O’Farrell, P ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new facility will produce APIs for small-molecule medicines, including those targeting oncology, cardiometabolic health, immunology and neuroscience. It will create 615 permanent jobs, including positions for scientists, engineers, lab technicians and operations personnel. The construction phase will generate 4,000 jo ...